Achiko AG's Breakthrough: Steven Goh on AptameX and Advancements in COVID-19 Testing | Steven Goh, CEO, Achiko AG. 00:10:00
teven Goh, CEO of Achiko AG, reveals the successful completion of validated testing for their innovative coronavirus rapid test, AptameX, in Indonesia. Goh highlights that the data gathered will support the company's application for CE mark approval in Europe, a crucial step towards wider distribution. He emphasizes that Achiko's DNA aptamer diagnostic test offers "dramatically more accurate results" than existing rapid tests, boasting sensitivity levels comparable to those of traditional PCR tests.
